# Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation

> **NCT02008448** · PHASE2 · UNKNOWN · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 160 (estimated)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **PROCEDURE:** Pulmonary vein isolation
- **PROCEDURE:** Linear Lesion Ablation
- **DRUG:** BT injection

## Key facts

- **NCT ID:** NCT02008448
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008448, "Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02008448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*